CLOV: Reynoso Jamie L. sold $86K of stock
By AlphaYouPublished Form 4
Reynoso Jamie L.
Reporting filer
Reynoso Jamie L. reported selling 18,273 shares of Clover Health Investments, Corp. /de for about $86K ($4.68 a share on average). Form 4 filed Oct 19, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Reynoso Jamie L. | 2026-10-15 | S | Sale | 18273 | 4.68 | 2,774,417 | 4 days | Filed terms
|
Class A Common Stock
- Owner
- Reynoso Jamie L.
- Date
- 2026-10-15
- Code
- S
- Action
- Sale
- Quantity
- 18273
- Price
- 4.68
- Following holdings
- 2,774,417
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Class A Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 18273
- id: F1
- transaction Price Per Share: 4.68
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 2774417
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Reynoso Jamie L.: CEO, Medicare Advantage.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.